Vaspin inhibited proinflammatory cytokine induced activation of nuclear factor-kappa B and its downstream molecules in human endothelial EA.hy926 cells

Diabetes Research and Clinical Practice

Volumn 103, Issue 3, 2014, Pages 482-488

  Liu, Shiwei ^a   Dong, Yanting ^a   Wang, Tong ^a   Zhao, Shujun ^a   Yang, Kun ^a   Chen, Xiaoqin ^a   Zheng, Caihong ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Endothelium; Inflammation; Insulin resistance; NF B; Vaspin

Indexed keywords

ENDOTHELIUM; INFLAMMATION; INSULIN RESISTANCE; NF-ΚB; VASPIN;

BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINE CCL2; CYTOKINES; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; INTERLEUKIN-6; LUCIFERASES; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERPINS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84898886331     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.12.002     Document Type: Article

References (45)

1. Shoelson S.E., Herrero L., Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007, 132:2169-2180.
2. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010, 72:219-246.
3. Samuel V.T., Shulman G.I. Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148:852-871.
4. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Network 2006, 17:4-12.
5. Gulcelik N.E., Usman A., Gurlek A. Role of adipocytokines in predicting the development of diabetes and its late complications. Endocrine 2009, 36:397-403.
6. Halberg N., Wernstedt-Asterholm I., Scherer P.E. The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 2008, 37:753-768.
7. Li Q., Chen R., Moriya J., Yamakawa J., Sumino H., Kanda T., et al. A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity. J Int Med Res 2008, 36:625-629.
8. Hida K., Wada J., Eguchi J., Zhang H., Baba M., Seida A., et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. PNAS 2005, 102:10610-10615.
9. Bluher M. Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 2012, 41:176-182.
10. Li H., Peng W., Zhuang J., Lu Y., Jian W., Wei Y., et al. Vaspin attenuates high glucose-induced vascular smooth muscle cells proliferation and chemokinesis by inhibiting the MAPK, PI3K/Akt, and NF-kappaB signaling pathways. Atherosclerosis 2013, 228:61-68.
11. Phalitakul S., Okada M., Hara Y., Yamawaki H. Vaspin prevents TNF-alpha-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-kappaB and PKCtheta activation in cultured rat vascular smooth muscle cells. Pharmacol Res 2011, 64:493-500.
12. Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol 2008, 103:398-406.
13. Barrett E.J., Liu Z. The endothelial cell: an "early responder" in the development of insulin resistance. Rev Endocr Metab Disord 2013, 14:21-27.
14. Shoelson S.E., Lee J., Yuan M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 2003, 27:S49-S52.
15. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 2005, 115:1111-1119.
16. Schenk S., Saberi M., Olefsky J.M. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008, 118(9):2992-3002.
17. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005, 11:183-190.
18. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001, 293:1673-1677.
19. Hasegawa Y., Saito T., Ogihara T., Ishigaki Y., Yamada T., Imai J., et al. Blockade of the nuclear factor-kappaB pathway in the endothelium prevents insulin resistance and prolongs life spans. Circulation 2012, 125:1122-1133.
20. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992, 41:1422-1428.
21. Nakatsuka A., Wada J., Iseda I., Teshigawara S., Higashio K., Murakami K., et al. Visceral adipose tissue-derived serine proteinase inhibitor inhibits apoptosis of endothelial cells as a ligand for the cell-surface GRP78/voltage-dependent anion channel complex. Circ Res 2013, 112:771-780.
22. Song C., Krell P., Yoo D. Nonstructural protein 1alpha subunit-based inhibition of NF-kappaB activation and suppression of interferon-beta production by porcine reproductive and respiratory syndrome virus. Virology 2010, 407:268-280.
23. Islam S., Hassan F., Mu M.M., Ito H., Koide N., Mori I., et al. Piceatannol prevents lipopolysaccharide (LPS)-induced nitric oxide (NO) production and nuclear factor (NF)-kappaB activation by inhibiting IkappaB kinase (IKK). Microbiol Immunol 2004, 48:729-736.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC(T)) method. Methods 2001, 25:402-408.
25. Wang P., Mariman E., Renes J., Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 2008, 216:3-13.
26. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
27. Smale S.T. Luciferase assay. Cold Spring Harbor Protoc 2010, 5.
28. Fu B.D., Yamawaki A., Okada M., Yukio Hra Y. Vaspin can not inhibit TNF-α-induced inflammation of human umbilical vein endothelial cells. J Vet Med Sci 2009, 71:1201-1207.
29. Aranda E., Owen G.I. A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line. Biol Res 2009, 42:377-389.
30. Unger R.E., Krump-Konvalinkova V., Peters K., Kirkpatrick C.J. In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res 2002, 64:384-397.
31. Trujillo M.E., Scherer P.E. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005, 257:167-175.
32. Neumeier M., Weigert J., Schaffler A., Wehrwein G., Muller L.U., Scholmerich J., et al. Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol 2006, 79:803-808.
33. Hulte J., Hulten L.M., Fagerberg B. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism 2002, 52:1612-1614.
34. Ukkola O., Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities?. J Mol Med 2002, 80:696-702.
35. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001, 86:3815-3819.
36. Davies M.J., Gordon J.L., Gearing A.J., Pigott R., Woolf N., Katz D., et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993, 171:223-229.
37. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
38. de Winther M.P., Kanters E., Kraal G., Hofker M.H. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005, 25:904-914.
39. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., Koh G.Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 2001, 276:7614-7620.
40. Anand A.R., Bradley R., Ganju R.K. LPS-induced MCP-1 expression in human microvascular endothelial cells is mediated by the tyrosine kinase, Pyk2 via the p38 MAPK/NF-kappaB-dependent pathway. Mol Immunol 2009, 46:962-968.
41. Lu Y., Zhu X., Liang G.X., Cui R.R., Liu Y., Wu S.S., et al. Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-kappaB/JNK signal pathway in human umbilical vein endothelial cells. Amino Acids 2012, 43:2125-2136.
42. Zhou Z., Connell M.C., MacEwan D.J. TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal 2007, 19:1238-1248.
43. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170:191-203.
44. Galkina E., Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:2292-2301.
45. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009, 29:313-326.